Reduction of bone turnover markers with annual infusion of zoledronic acid 5 mg in postmenopausal osteoporosis: Influence of age, renal function, concomitant therapy, and duration of treatment

JOURNAL OF BONE AND MINERAL RESEARCH(2007)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要